Enzolytics Inc. (ENZC)
OTHER OTC:ENZC
US Market
Holding ENZC?
Track your performance easily

Enzolytics (ENZC) Stock Price & Analysis

464 Followers

ENZC Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

<0.01%100.00%
Insiders
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors

ENZC FAQ

What was Enzolytics Inc.’s price range in the past 12 months?
Enzolytics Inc. lowest stock price was <$0.01 and its highest was $0.03 in the past 12 months.
    What is Enzolytics Inc.’s market cap?
    Currently, no data Available
    When is Enzolytics Inc.’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Enzolytics Inc.’s earnings last quarter?
    Currently, no data Available
    Is Enzolytics Inc. overvalued?
    According to Wall Street analysts Enzolytics Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Enzolytics Inc. pay dividends?
      Enzolytics Inc. pays a Notavailable dividend of $156.25 which represents an annual dividend yield of N/A. See more information on Enzolytics Inc. dividends here
        What is Enzolytics Inc.’s EPS estimate?
        Enzolytics Inc.’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Enzolytics Inc. have?
        Enzolytics Inc. has 4,791,646,500 shares outstanding.
          What happened to Enzolytics Inc.’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Enzolytics Inc.?
          Currently, no hedge funds are holding shares in ENZC
          ---

          Enzolytics Stock Smart Score

          10
          Unlock Smart Score
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Fundamentals

          Return on Equity
          Trailing 12-Months
          Asset Growth
          8072.19%
          Trailing 12-Months

          Company Description

          Enzolytics Inc.

          Enzolytics, Inc. is a development stage company, which engages in the research and development on the operations and treatment of HIV/Aids virus. It focuses on the commercialization of the license rights of the IPF for the treatment of Aids and Hepatitis C as well as potential other treatments for life threatening diseases. The company was founded on July 28, 2004 and is headquartered in Monrovia, CA.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Inovio Pharmaceuticals
          BioRestorative Therapies
          CytoDyn
          Northwest Biotherapeutics
          Popular Stocks
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis